# Sunshine Biopharma Inc.: Form 8-K, filed Mar 6, 2024

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2024-03-06
- Accepted by EDGAR: Mar 6, 2024, 16:05 ET
- Period: 2024-03-04
- Accession: 0001683168-24-001357
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001357/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001357/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316824001357/sunshine_8k.htm

Filed Mar 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-001357. Last ingested by Listed: Nov 11, 2026, 03:50 ET. No prices; not investment advice.